RheumaGen & SiVEC partner to co-develop scalable gene-editing therapies to cure autoimmune diseases using SiVEC’s BactPac™ platform.
CU Anschutz
Anschutz Health Sciences Building
1890 N Revere Ct
Suite 6202
Aurora, CO 80045
RheumaGen and SiVEC Biotechnologies Announce CGT Partnership and In Vivo Program to Cure Common Autoimmune Diseases
Default sub title
minute read
by PR Newswire | October 7, 2025
